| P/E (FY) | — | Sales (TTM) | $21,796 |
| Earnings (TTM) | -$9.2M | ROE | — |
| Net Margin | −39662.77% | ROIC | — |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
| Market Cap | $4.0M | Trading Days | 405 |
| 52W High | 1.84 |
| 52W Low | 0.10 |
| % Off High | −94.04% |
| YTD | −89.25% | 1Y | −93.06% |
| Since incept. (ann.) | −90.69% |
| Ann. Volatility (1Y) | 113.88% | Ann. Volatility (3Y) | 148.05% |
| Sharpe (1Y) | −1.81 | Sharpe (3Y) | −0.85 |
| Max Drawdown (1Y) | −93.91% | Max Drawdown (3Y) | −99.29% |
| Beta (3Y, vs SPY) | 2.02 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| SXTP | 60 DEGREES PHARMACEUTICALS, INC. | $4.0M | — |
| REVB | REVELATION BIOSCIENCES, INC. | $4.1M | — |
| CVSI | CV Sciences, Inc. | $4.1M | — |
| ENSC | Ensysce Biosciences, Inc. | $3.7M | — |
| ELAB | PMGC Holdings Inc. | $4.3M | — |
| ACUT | Accustem Sciences Inc. | $3.5M | — |
| INBP | INTEGRATED BIOPHARMA INC | $4.7M | 5.0 |
| RNAZ | Transcode Therapeutics, Inc. | $4.8M | — |
| ENVB | Enveric Biosciences, Inc. | $4.9M | — |
| DRMA | Dermata Therapeutics, Inc. | $5.0M | — |
| APVO | Aptevo Therapeutics Inc. |
| $5.2M |
| — |
| GOVX | GeoVax Labs, Inc. | $5.4M | — |
